Bringing these next-generation sweeteners to market requires world-class biotechnology. IFF combines scientific expertise with state-of-the-art discovery and screening techniques to deliver advanced commercial epimerases.
Manufacturers can adopt IFF’s advanced sugar-conversion technology without completely rewriting their manufacturing process. Our enzymes are designed as a simple, modular add-on that integrates directly into an existing sweetener refinery process. This drop-in capability allows producers to diversify their portfolios into premium, low-calorie alternatives using their existing starch infrastructure.
IFF has developed advanced enzymes that can efficiently produce emerging alternative sweeteners, such as allulose. Allulose is a naturally occurring rare sugar found in small amounts in foods like dried fruits, molasses, and maple syrup. Key properties of allulose include:
CITATIONS:
Ready to unlock new possibilities? Contact our experts to discover how IFF’s innovative solutions can help optimize performance, create value, and support your business goals.